Link to this page
Medical Subject Headings
| Preferred Name | Cidofovir | |
| Synonyms |
1-(3-Hydroxy-2-phosphonylmethoxypropyl)cytosine Cidofovir, Sodium Salt Cidofovir Sodium Cidofovir, (+-)-isomer GS-504 Vistide Phosphonic acid, (((1S)-2-(4-amino-2-oxo-1(2H)-pyrimidinyl)-1-(hydroxymethyl)ethoxy)methyl)- GS 504 Cidofovir, (R)-isomer HPMPC Cidofovir Anhydrous GS504 1-((3-Hydroxy-2-phosphonylmethoxy)propyl)cytosine |
|
| Definitions |
An acyclic nucleoside phosphonate that acts as a competitive inhibitor of viral DNA polymerases. It is used in the treatment of RETINITIS caused by CYTOMEGALOVIRUS INFECTIONS and may also be useful for treating HERPESVIRUS INFECTIONS. |
|
| ID |
http://purl.bioontology.org/ontology/MESH/D000077404 |
|
| altLabel |
1-(3-Hydroxy-2-phosphonylmethoxypropyl)cytosine Cidofovir, Sodium Salt Cidofovir Sodium Cidofovir, (+-)-isomer GS-504 Vistide Phosphonic acid, (((1S)-2-(4-amino-2-oxo-1(2H)-pyrimidinyl)-1-(hydroxymethyl)ethoxy)methyl)- GS 504 Cidofovir, (R)-isomer HPMPC Cidofovir Anhydrous GS504 1-((3-Hydroxy-2-phosphonylmethoxy)propyl)cytosine
|
|
| AQL |
AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR
|
|
| cui |
C2699210 C0957903 C0957905 C0286077 C0286079 C0286078 C0957904
|
|
| DC |
1
|
|
| definition |
An acyclic nucleoside phosphonate that acts as a competitive inhibitor of viral DNA polymerases. It is used in the treatment of RETINITIS caused by CYTOMEGALOVIRUS INFECTIONS and may also be useful for treating HERPESVIRUS INFECTIONS.
|
|
| DX |
20190101
|
|
| HN |
2019 (1989)
|
|
| Inverse of AQ |
http://purl.bioontology.org/ontology/MESH/Q000097 http://purl.bioontology.org/ontology/MESH/Q000627 http://purl.bioontology.org/ontology/MESH/Q000493 http://purl.bioontology.org/ontology/MESH/Q000494 http://purl.bioontology.org/ontology/MESH/Q000276 http://purl.bioontology.org/ontology/MESH/Q000138 http://purl.bioontology.org/ontology/MESH/Q000134 http://purl.bioontology.org/ontology/MESH/Q000266 http://purl.bioontology.org/ontology/MESH/Q000378 http://purl.bioontology.org/ontology/MESH/Q000008 http://purl.bioontology.org/ontology/MESH/Q000009 http://purl.bioontology.org/ontology/MESH/Q000031 http://purl.bioontology.org/ontology/MESH/Q000032 http://purl.bioontology.org/ontology/MESH/Q000037 http://purl.bioontology.org/ontology/MESH/Q000191 http://purl.bioontology.org/ontology/MESH/Q000302 http://purl.bioontology.org/ontology/MESH/Q000145 http://purl.bioontology.org/ontology/MESH/Q000592 http://purl.bioontology.org/ontology/MESH/Q000737 http://purl.bioontology.org/ontology/MESH/Q000819 http://purl.bioontology.org/ontology/MESH/Q000506 http://purl.bioontology.org/ontology/MESH/Q000633 http://purl.bioontology.org/ontology/MESH/Q000600 |
|
| Inverse of RB |
JIL713Q00N M83JB37U61 768M1V522C 128347-13-7 0
|
|
| isa | ||
| LT |
TRD
|
|
| Machine permutation |
2019; CIDOFOVIR was indexed under CYTOSINE/analogs & derivatives 1989-2018; under ORGANOPHOSPHONATES 2005-2018; and under ORGANOPHOSPHORUS COMPOUNDS 1989-2004
|
|
| Mapped from | ||
| MDA |
20180709
|
|
| MMR |
20180703
|
|
| MN |
D02.705.429.437 D03.383.742.698.421.216
|
|
| notation |
D000077404
|
|
| PA |
D000998 D004791
|
|
| prefLabel |
Cidofovir
|
|
| RR |
113852-37-2 (Cidofovir) M83JB37U61 128347-13-7 ((+-)-Isomer) 768M1V522C
|
|
| TERMUI |
T000939598 T194906 T000939601 T000939579 T000939597 T000939600 T000939578 T194908 T194909 T194907 T000939599 T000939577
|
|
| TH |
US UK FDA SRS (2013) USAN (1994) NLM (2013) DE AU NLM (1989) FR
|
|
| tui |
T114 T121
|
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |